Skip to main content
Advertisement
Table of Contents

May 2025

Cover

Severe acute malnutrition (SAM) in children under five poses a huge burden globally, with the Democratic Republic of Congo being one of the worst-affected countries. Ready-to-use therapeutic food (RUTF) is used in the management of children suffering from SAM to make up for lost weight and tissue mass. In 2023 the WHO recommended the use of a reduced dose of RUTF strategy after a carefully assessing the child and household situation. This could be particularly useful in settings with limited resources or situations where the supply of RUTF is challenging, but there is insufficient evidence on the best dosing strategy. In this study, Julien Ntaongo Alendi and colleagues compare the effectiveness of a reduced RUTF dosage to a standard dosage in children suffering from SAM without medical complications in a non-inferiority randomized controlled trial in the Democratic Republic of Congo.

Image Credit: We would like to acknowledge Suaahara II for the use of this image (Food - Ready to use therapeutic food - 00A - Nepal) accessed from the USAID Advancing Nutrition-UNICEF IYCF Digital Image Bank (iycf.advancingnutrition.org). Commercial use, redistribution, or selling of these images and materials is prohibited.

Research Articles

Change in willingness for surgery and risk of joint replacement after an education and exercise program for hip/knee osteoarthritis: A longitudinal cohort study of 55,059 people

Belinda J. Lawford, Ali Kiadaliri, Martin Englund, Kim L. Bennell, Rana S. Hinman, Michelle Hall, Andrea Dell’Isola

Adolescent cardiorespiratory fitness and risk of cancer in late adulthood: A nationwide sibling-controlled cohort study in Sweden

Marcel Ballin, Daniel Berglind, Pontus Henriksson, Martin Neovius, Anna Nordström, Francisco B. Ortega, Elina Sillanpää, Peter Nordström, Viktor H. Ahlqvist

Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants

Yuli Lily Hsieh, C. Robert Horsburgh Jr, Ted Cohen, Jeffrey W. Miller, Joshua A. Salomon, Nicolas A. Menzies

Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial)

Stefan Halbherr, Stefanie Lerch, Sebastian Bellwald, Petra Polakova, Bettina Bannert, Marie Roumet, Roch-Philippe Charles, Martin A. Walter, Corrado Bernasconi, Valérie Lisa Halbherr, Camille Peitsch, Pascal C. Baumgartner, Céline Kaufmann, Vanessa Aires, Heinrich P. Mattle, Alain Kaelin-Lang, Andreas Hartmann, Michael Schuepbach

The comparative effectiveness and safety of fluticasone-salmeterol via metered-dose versus dry powder inhalers for COPD: A new user cohort study

Brandon J. Demkowicz, Kevin Rader, Shirley V. Wang, Aaron S. Kesselheim, William B. Feldman

Effectiveness of a reduced dose of ready-to-use therapeutic food in community-based management of severe acute malnutrition: A non-inferiority randomized controlled trial in the Democratic Republic of Congo

Julien Ntaongo Alendi, Cécile Salpeteur, Steve Botomba, Alemayehu Argaw, Victor Nikièma, Jean-Baptiste Mayavanga, Benjamin Guesdon, Marie Petry, Uwimana Sebinwa, Sophie Bruneau, Aimée Mupuala Masaya, Florence Mbiya Muadi, Samuel Mampunza Ma Miezi, Marie-Claire Muyer

Identification and validation of poly-metabolite scores for diets high in ultra-processed food: An observational study and post-hoc randomized controlled crossover-feeding trial

Leila Abar, Eurídice Martínez Steele, Sang Kyu Lee, Lisa Kahle, Steven C. Moore, Eleanor Watts, Caitlin P. O’Connell, Charles E. Matthews, Kirsten A. Herrick, Kevin D. Hall, Lauren E. O’Connor, Neal D. Freedman, Rashmi Sinha, Hyokyoung G. Hong, Erikka Loftfield

Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America

Sabine Naudin, Molin Wang, Niki Dimou, Elmira Ebrahimi, Jeanine Genkinger, Hans-Olov Adami, Demetrius Albanes, Ana Babic, Matt Barnett, David Bogumil, Hui Cai, Chu Chen, A. Heather Eliassen, Jo L. Freudenheim, Gretchen Gierach, Edward L. Giovannucci, Marc J. Gunter, Niclas Håkansson, Mayo Hirabayashi, Tao Hou, Brian Z. Huang, Wen-Yi Huang, Harindra Jayasekara, Michael E. Jones, Verena A. Katzke, Woon-Puay Koh, James V. Lacey, Ylva Trolle Lagerros, Susanna C. Larsson, Linda M. Liao, Kenneth Lo, Erikka Loftfield, Robert J. MacInnis, Satu Männistö, Marjorie L. McCullough, Anthony Miller, Roger L. Milne, Steven C. Moore, Lorelei A. Mucci, Marian L. Neuhouser, Alpa V. Patel, Elizabeth A. Platz, Anna Prizment, Kim Robien, Thomas E. Rohan, Carlotta Sacerdote, Sven Sandin, Norie Sawada, Minouk Schoemaker, Xiao-Ou Shu, Rashmi Sinha, Linda Snetselaar, Meir J. Stampfer, Rachael Stolzenberg-Solomon, Cynthia A. Thomson, Anne Tjønneland, Caroline Y. Um, Piet A. van den Brandt, Kala Visvanathan, Sophia S. Wang, Renwei Wang, Elisabete Weiderpass, Stephanie J. Weinstein, Emily White, Walter Willett, Alicja Woslk, Brian M. Wolpin, Shiaw-Shyuan S. Yaun, Chen Yuan, Jian-Min Yuan, Wei Zheng, Paul Brennan, Stephanie A. Smith-Warner, Pietro Ferrari

Related Articles

Short-term exposure to ambient temperature variability and myocardial infarction hospital admissions: A nationwide case-crossover study in Sweden

Wenli Ni, Massimo Stafoggia, Siqi Zhang, Petter Ljungman, Susanne Breitner, Jeroen de Bont, Tomas Jernberg, Dan Atar, Alexandra Schneider, Stefan Agewall

Twenty-year outcomes after repeat doses of antenatal corticosteroids prior to 32 weeks’ gestation: Follow-up of a randomised clinical trial

Robyn W. May, Anthony G. B. Walters, Greg D. Gamble, Caroline A. Crowther, Stuart R. Dalziel, Carl L. Eagleton, Christopher J. D. McKinlay, Barry J. Milne, Jane E. Harding

Correction

Correction: Determining optimal timing of birth for women with chronic or gestational hypertension at term: The WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised trial

Laura A. Magee, Katie Kirkham, Sue Tohill, Eleni Gkini, Catherine A. Moakes, Jon Dorling, Marcus Green, Jennifer A. Hutcheon, Mishal Javed, Jesse Kigozi, Ben W. M. Mol, Joel Singer, Pollyanna Hardy, Clive Stubbs, James G. Thornton, Peter von Dadelszen, for the WILL Trial Study Group

Related Articles